ArticleJMIR formative research2025
Bactericidal Efficacy of Ultraviolet-C Light on Virtual Reality Devices: In Vitro Assessment of Bacterial Killing.
Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background: Virtual reality (VR) headsets are increasingly used in health care settings for a variety of clinical indications, yet processes to ensure safe use between patients are not well-established. Centers vary in how these processes are performed. Most use disinfection wipes that require manual contact with VR devices for a specified dwell time to allow for sufficient pathogen killing, which may introduce manual error and device degradation over time. Ultraviolet-C light (UV-C) devices offer a no-touch, low-cost, and passive method to achieve pathogen killing without the harms of chemical contact-based disinfectants. The use of UV-C for disinfection has been studied for some medical devices but its efficacy for microbe killing on VR headsets is not well-established. Objective: This study aims to determine the bactericidal efficacy of UV-C on VR headsets through quantifying UV-C irradiance and bacterial killing of 3 commercially available UV-C devices. Methods: Three commercially available, low-cost UV-C devices were tested for UV-C energy output at multiple positions, angles, and times across the devices' zone of disinfection. The top and lens of a VR headset, the Meta Oculus Quest 2, were artificially inoculated with high quantities of 3 different strains of bacteria (Staphylococcus aureus, Pseudomonas aeruginosa, and Staphylococcus epidermidis) and subjected to UV-C light according to each device's manufacturer's instructions for use. The primary outcome was the amount of bacterial killing after exposure to UV-C light. Results: All 3 UV-C devices produced a UV-C dose that ranged from 3.57 to 195.37 mJ/cm2, depending on proximity, angle, irradiance, and time the sensor received. At least 3-log10 killing of all 3 strains of bacteria was achieved for each of the tested UV-C devices; however, there was variability by organism with respect to UV-C device and VR headset location within the device, notably with the proximity of the bacteria to the bulb. S aureus and P aeruginosa were more readily killed than S epidermidis, with increased bacterial killing occurring with increased UV-C exposure doses. There was no experiment in which all bacteria were killed. Conclusions: UV-C dosage increased with exposure irradiance, time, proximity, and angle to the bulb for all 3 UV-C devices. Bacterial killing on the top and lens of a VR headset occurred in all 3 UV-C devices when run according to their manufacturer's instructions for use, although full bacterial killing did not occur in any experiment. UV-C may be an effective method for microbial killing on VR equipment with low-level contamination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.